J Back Musculoskelet Rehabil
July 2022
Background: Low back pain is a significant spinal disorder that affects much of the population at some point during their lives.
Objective: While proper diagnosis is key, diagnosing the underlying cause of low back pain may often be unclear.
Method: In this review article, we discuss lumbar instability as an etiology of low back pain and its treatment by prolotherapy.
Clin Med Insights Arthritis Musculoskelet Disord
July 2016
Objective: The aim of this study was to systematically review dextrose (d-glucose) prolotherapy efficacy in the treatment of chronic musculoskeletal pain.
Data Sources: Electronic databases PubMed, Healthline, OmniMedicalSearch, Medscape, and EMBASE were searched from 1990 to January 2016.
Study Selection: Prospectively designed studies that used dextrose as the sole active prolotherapy constituent were selected.
The use of conventional modalities for chronic neck pain remains debatable, primarily because most treatments have had limited success. We conducted a review of the literature published up to December 2013 on the diagnostic and treatment modalities of disorders related to chronic neck pain and concluded that, despite providing temporary relief of symptoms, these treatments do not address the specific problems of healing and are not likely to offer long-term cures. The objectives of this narrative review are to provide an overview of chronic neck pain as it relates to cervical instability, to describe the anatomical features of the cervical spine and the impact of capsular ligament laxity, to discuss the disorders causing chronic neck pain and their current treatments, and lastly, to present prolotherapy as a viable treatment option that heals injured ligaments, restores stability to the spine, and resolves chronic neck pain.
View Article and Find Full Text PDFClin Med Insights Arthritis Musculoskelet Disord
March 2014
We retrospectively evaluated the effectiveness of prolotherapy in resolving pain, stiffness, and crepitus, and improving physical activity in consecutive chondromalacia patients from February 2008 to September 2009. Sixty-nine knees that received prolotherapy in 61 patients (33 female and 36 male) who were 18-82 years old (average, 47.2 years) were enrolled.
View Article and Find Full Text PDFClin Med Insights Arthritis Musculoskelet Disord
September 2013